SCHEMBL7684369

SCHEMBL7684369

COc1cc(-c2csc(N)n2)c(OC)cc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ MEN1 O00255 7/20 0.49
▸ KMT2A Q03164 7/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ MAPT P10636 6/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ THRB P10828 2/20 0.46
▸ POLB P06746 1/20 0.45
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ HSD17B10 Q99714 2/20 0.43
▸ PLAU P00749 1/20 0.42
▸ TYR P14679 1/20 0.41
▸ GFER P55789 2/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ RECQL P46063 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8893338 0.88 ALDH1A1 (0.65) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL8895685 0.86 ALDH1A1 (0.63) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL27566802 0.80 ALDH1A1 (0.56) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL12248758 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL7228762 0.79 ALDH1A1 (0.62) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL8894539 0.79 ALDH1A1 (0.67) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL7681878 0.77 ALDH1A1 (0.43) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL1821573 0.76 CYP1A1 (0.75) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL30641473 0.76 ALDH1A1 (0.71) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL5328182 0.76 RAB9A (0.71) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380230-B1 FOR THERAPY OF DYSKINESIA, OBESITY, IRRITABLE BOWEL SYNDROME, DISEASES WHOSE TREATMENT REQUIRES STIMULATION OF THE CHOLECYSTOKININ CCK-A RECEPTORS SANOFI-SYNTHELABO (FR) 2002-04-30 — — US disclosed
EP-1017693-A1 CARBOXAMIDOTHIAZOLE DERIVATIVES, PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI-SYNTHELABO (FR) 2000-07-12 — — EP disclosed
WO-1999015525-A1 CARBOXAMIDOTHIAZOLE DERIVATIVES, PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI-SYNTHELABO (FR) 1999-04-01 — — WO disclosed
US-5656648-A TREATMENT OF PATHOLOGIES NECESSITATING STIMULATION OF CHOLECYSTOKININ-A RECEPTORS BY TOTAL OR PARTIAL AGONIST EFFECT SANOFI (FR) 1997-08-12 — — US disclosed
CN-1107158-A Polysubstituted 2-amino-thiazole derivatives SANOFI ELF (FR) 1995-08-23 — — CN disclosed
EP-0611766-A1 Polysubstituted 2-amido thiazoles derivatives, process for their preparation, pharmaceutical compositions and utilization for the preparation of a medicament SANOFI (FR) 1994-08-24 — — EP disclosed
Send feedback